AzTrials
AzTrials

SuicideNCT05307432

Safety Planning Intervention Telehealth Service Model in Emergency Departments

A study testing SPI+ Delivered by ED Staff and SPI+ Delivered by SPCC Clinicians in people with Suicide and Suicidal Ideation, run by University of Pennsylvania at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness and implementation of a suicide prevention strategy delivered via telehealth in Emergency Departments. We will compare implementation of the Safety Planning Intervention plus follow-up calls (SPI+) delivered by Emergency Department (ED) staff to SPI+ delivered… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicide, Suicidal Ideation
What is being tested?
SPI+ Delivered by ED Staff and SPI+ Delivered by SPCC Clinicians
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,814 participants
Where
1 siteUnited States
Study dates
1 May 2022to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ED visit at one of our participating sites for a suicide-related event or determined to be at risk for suicide per the Electronic Health Record (EHR) and ED clinical staff
  • 18 years of age or older
  • Not admitted to an inpatient hospital following the index ED visit as documented in the EHR
  • ED clinician or leader at one of our participating sites, or ED patient who was referred to the SPCC
  • 18 years of age or older
  • Able to communicate in English
  • Willing to give informed consent

Who cannot join

  • Inpatient admission following the index ED visit per the EHR
  • Aim 2:
  • Patients who are at imminent risk of suicide or acutely psychotic at the time of the interview, requiring emergency services and/or precluding ability to provide informed consent
  • Patients without a phone for contact

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: A Safety Planning Intervention and Follow-up Telehealth Service Model for Suicidal Individuals in Emergency Department Settings

The purpose of this study is to evaluate the effectiveness and implementation of a suicide prevention strategy delivered via telehealth in Emergency Departments. We will compare implementation of the Safety Planning Intervention plus follow-up calls (SPI+) delivered by Emergency Department (ED) staff to SPI+ delivered via ED referral to an off-site Suicide Prevention Consultation Center (SPCC).

Read the detailed description

Individuals at high risk for suicide often present to acute care settings, such as emergency departments (EDs), and then typically are hospitalized or referred for outpatient mental health treatment. Patients are at increased risk of suicide attempts and suicide following an ED visit and nearly half do not attend outpatient treatment. Brief, evidence-based clinical interventions, such as the Safety Planning Intervention with post-discharge telephone follow-up (SPI+), can reduce suicide risk, decrease hospitalizations, and increase engagement in outpatient services for suicidal patients discharged from the ED. Leveraging insights from implementation science and collaborative care, we propose a model in which ED staff will connect patients at risk for suicide to ED-credentialed mental health clinicians who are located external to the ED. These off-site clinicians will provide SPI+ via telehealth for ED patients prior to discharge and provide follow-up services after ED discharge as part of an innovative Suicide Prevention Consultation Center (SPCC). All participating EDs will begin in the Enhanced Usual Care phase, in which ED staff will deliver SPI+ to suicidal patients. EDs will then be randomized in pairs to begin referral to the SPCC in 3 month intervals. We will also conduct a cost evaluation to help determine scalability and sustainability.

Being tested
SPI+ Delivered by ED Staff, SPI+ Delivered by SPCC Clinicians
Keywords
Safety Planning, Emergency Department, Risk Assessment, Follow-up Contact, Implementation Strategies, Telehealth
Medical subject headings
Suicide, Suicidal Ideation, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPI+ Delivered by ED StaffBehavioural

    ED staff will deliver SPI+ (Safety Planning Intervention plus follow-up phone calls) to patients at risk for suicide in the ED who are not admitted to an inpatient unit.

  • SPI+ Delivered by SPCC CliniciansBehavioural

    The Suicide Prevention Consultation Center (SPCC) will be located external to the Emergency Department (ED). ED staff will be able to refer patients at risk for suicide to the SPCC. Licensed and credentialed mental health clinicians will deliver SPI+ (Safety Planning Intervention plus follow-up phone calls) via telehealth to patients at risk for suicide in the ED who are not admitted to an inpatient unit.

Study groups in NCT05307432
Study groupRoleWhat they receive
Enhanced Usual CareActive comparatorED staff deliver SPI+ (Safety Planning Intervention plus 2 or more post-discharge telephone calls) to suicidal patients who are not admitted to an inpatient unit.
Receives: Behavioral: SPI+ Delivered by ED Staff
Suicide Prevention Consultation CenterExperimentalED staff refer suicidal patients not admitted to an inpatient unit to the off-site Suicide Prevention Consultation Center (SPCC). SPCC clinicians will deliver SPI+ (Safety Planning Intervention plus 2 or more post-discharge telephone calls) to patients via telehealth.
Receives: Behavioral: SPI+ Delivered by SPCC Clinicians

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicide Behavior Composite

    Number of patients who had a documented suicide attempt or death by suicide

    Measured: 6 months after index ED visit

  2. Outpatient Treatment Engagement - Count

    Number of behavioral healthcare visits following discharge from index ED visit

    Measured: 6 months after index ED visit

  3. Outpatient Treatment Engagement - Type

    Types of behavioral healthcare visits following discharge from index ED visit

    Measured: 6 months after index ED visit

  4. Safety Planning Intervention Scoring Algorithm (SPISA)

    Fidelity of written safety plans post-discharge from index ED visit

    Measured: At index ED visit

  5. Fidelity of Follow-up Calls

    Number of patients who had 2 or more follow-up calls post-discharge from index ED visit

    Measured: 1 month after index ED visit

  6. Reach/Penetration of Safety Plans

    Proportion of patients with a completed safety plan documented in the medical record out of all patients identified as at risk for suicide by the ED staff

    Measured: At index ED visit

  7. Reach/Penetration of Follow-up Calls

    Proportion of patients who receive 2 or more telephone follow-up attempts out of all patients who received a safety plan

    Measured: 1 month after index ED visit

Secondary outcomes (9)
  1. Suicide-related ED Visits and Psychiatric Hospitalizations

    Number of ED visits and/or inpatient psychiatric admissions for suicidal ideation/behavior

    Measured: 6 months after index ED visit

  2. Suicide Attempts

    Number of patients who had a documented suicide attempt

    Measured: 6 months after index ED visit

  3. Adoption

    Proportion of clinicians with eligible patients who refer the patient to the SPCC

    Measured: At index ED visit

  4. Utilization of Screening of Suicide Risk Among ED Patients

    Proportion of ED patients who received the Columbia Suicide Severity Rating Scale or equivalent evidence-based measure of suicide risk during index ED visit

    Measured: At index ED visit

  5. Index ED Visit Inpatient Admission Disposition

    Proportion of patients admitted for inpatient hospitalization out of all patients identified as at risk for suicide

    Measured: At index ED visit

  6. Feasibility of SPCC

    Will be assessed through semi-structured qualitative interviews with a randomly selected sample of clinicians, leaders, and patients, as well as by using the Feasibility of Intervention Measure (FIM)

    Measured: 9-12 months after ED crosses over to SPCC condition

  7. Acceptability of SPCC

    Will be assessed through semi-structured qualitative interviews with a randomly selected sample of clinicians, leaders, and patients, as well as by using the Acceptability of Intervention Measure (AIM)

    Measured: 9-12 months after ED crosses over to SPCC condition

  8. Cost to Emergency Department of SPCC

    We will assess average personnel and non-personnel costs to Emergency Department practices of delivering SPCC and EUC strategies, using Time-Driven Activity-Based Costing

    Measured: After ED crosses over to SPCC condition (2.25 - 3 year range, average of 2.625 years)

  9. Cost to Emergency Department of EUC

    We will assess average personnel and non-personnel costs to Emergency Department practices of delivering EUC strategies, using Time-Driven Activity-Based Costing

    Measured: Before ED crosses over to SPC condition (1 - 1.75 year range, average of 1.375 years)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2022
  2. Study start1 May 2022
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Model description
Stepped-wedge cluster-randomized controlled design
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
2,814 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05307432
Sponsor's protocol ID
850636
Other IDs
1P50MH127511-01
Status last verified
Jul 2026
First submitted
2 Mar 2022
Last updated
28 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing SPI+ Delivered by ED Staff and SPI+ Delivered by SPCC Clinicians in people with Suicide and Suicidal Ideation, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 28 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suicide Behavior Composite (time frame: 6 months after index ED visit). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05307432 | AzTrials